KALV — KALVISTA PHARMACEUTICALS INC

Ownership history in HAP Trading, LLC  ·  1 quarter on record

This page tracks every 13F SEC filing in which HAP Trading, LLC reported a position in KALVISTA PHARMACEUTICALS INC (KALV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q1 INITIATED 50,000 — — 0.00% $16.2M $11.54
% of Fund (quarterly)    KALV price (monthly, adj. close)

Other funds also holding KALV

As of 2025 Q4 — sorted by position size

SILVERARC CAPITAL MANAGEMENT, LLC 3Y 5.44% VR Adviser, LLC 3Y 5.37% Elmind Capital, LP 3.82% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 3.65% GREAT POINT PARTNERS LLC 3Y 7Y 3.59% Parkman Healthcare Partners LLC 3Y 2.72% Octagon Capital Advisors LP 3Y 2.5% Frazier Life Sciences Management, L.P. 3Y 2.19% Kynam Capital Management, LP 3Y 1.87% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 1.58%
← Back to HAP Trading, LLC Holdings